Daniel L. Alkon
58Patents
12h-index
20Co-inventors
84Inventor score
Filing activity: Aug 15, 1983 → Jul 26, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5822742A | Dynamically stable associative learning neural network system | Physics | 80 | Expired |
| US6107050A | Diagnostic test for alzheimers disease | Emerging Cross-Sectional Technologies | 67 | Expired |
| US5870493A | Top down preprocessor for a machine vision system | Physics | 42 | Expired |
| US5119469A | Neural network with weight adjustment based on prior history of input signals | Physics | 28 | Expired |
| US5588091A | Dynamically stable associative learning neural network system | Physics | 26 | Expired |
| US5222195A | Dynamically stable associative learning neural system with one fixed weight | Physics | 23 | Expired |
| US5446829A | Artificial network for temporal sequence processing | Physics | 22 | Expired |
| US6080582A | Cell tests for Alzheimer's disease | Physics | 21 | Expired |
| US5580748A | Diagnostic tests for alzheimers disease | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6552053B2 | Controlling attention and memory by altering neuronal carbonic anhydrase activity | Human Necessities | 17 | Expired |
| US5402522A | Dynamically stable associative learning neural system | Physics | 16 | Expired |
| US6300085A | Diagnostic method for Alzheimer's disease | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7595167B2 | Alzheimer's disease-specific alterations of the Erk1/Erk2 phosphorylation ratio | Physics | 12 | Expired |
| US7977377B2 | Treatment of depressive disorders | Human Necessities | 9 | Active |
| US6825229B2 | Methods for Alzheimer's Disease treatment and cognitive enhancement | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7220833B2 | Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8658134B2 | Fibroblast growth patterns for diagnosis of Alzheimer's disease | Physics | 8 | Active |
| US7803400B2 | Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier | Human Necessities | 7 | Active |
| US9119825B2 | PKC-activating compounds for the treatment of neurodegenerative diseases | Chemistry; Metallurgy | 4 | Active |
| US8163800B2 | PKC-activating compounds for the treatment of neurodegenerative diseases | Chemistry; Metallurgy | 4 | Active |
| US5976816A | Cell tests for alzheimer's disease | Physics | 4 | Expired |
| US9188595B2 | Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation | Physics | 4 | Active |
| US9163032B2 | Esters of DCPLA and methods of treatment using the same | Chemistry; Metallurgy | 3 | Active |
| US7682807B2 | Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation | Physics | 3 | Expired |
| US10323011B2 | PKC-activating compounds for the treatment of neurodegenerative diseases | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.